An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)

Status Recruiting

Clinical Trial Summary

The goal of this randomized trial is to test whether the Internet-Delivered Enhanced Assess, Acknowledge, Act (IDEA3) sexual assault resistance education intervention reduces sexual violence victimization in undergraduate women. Participants in the intervention group will be asked to attend four three-hour group sessions of a sexual assault resistance program called IDEA3 with a partner, as well as fill out a number of surveys. Participants in the control group will be asked to attend a one-hour consent workshop with a partner and fill out surveys. Researchers will compare sexual assault victimization between the groups in the one year following the intervention.

Clinical Trial Description

Sexual violence (SV), which occurs along a continuum from unwanted sexual contact to rape, is common among young women, with some 40% experiencing sexual assault during their time in college. Given the numerous negative consequences associated with SV, developing effective SV prevention and resistance programs for young adult women is critical for reducing victimization and improving health outcomes for adolescent girls. The Enhanced Assess, Acknowledge, Act (EAAA) sexual assault resistance program has been shown to substantially reduce rates of SV (50% for rape and attempted rape) in young women attending university (ages 17-24). The purpose of the current study is to test the efficacy of the newly adapted Internet-Delivered Enhanced Assess, Acknowledge, Act (IDEA3) program in reducing sexual violence victimization among undergraduate women over 12 months of follow-up. IDEA3 is a 12-hour psychoeducational intervention that provides information, skills, and practice aimed at a) decreasing the time needed for young women to assess sexually coercive situations as dangerous and to take action, b) reducing emotional obstacles to taking action, c) increasing the use of the most effective methods of verbal and physical self-defense, and d) identifying sexual and relationship values and boundaries and reinforcing the right to defend them. ;

Study Design

Related Conditions & MeSH terms

Sexual Assault

Clinical Trial Details

NCT number	NCT06058455
Study type	Interventional
Source	University of Michigan
Contact	Sarah M Peitzmeier, PhD
Phone	(734) 764-4176
Email	speitzme@umich.edu
Status	Recruiting
Phase	N/A
Start date	October 2, 2023
Completion date	September 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04160702` - Using VR to Assess the Efficacy of a Motivational Interviewing Intervention to Increase Bystander Behaviors	N/A
Completed	`NCT01338428` - Sexual Assault Resistance Education for University Women	Phase 2
Completed	`NCT01907126` - HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence	Phase 2
Active, not recruiting	`NCT05206994` - Evaluation of the Close to Home Program in California	N/A
Enrolling by invitation	`NCT05281874` - Personalized Integrated Alcohol and Sexual Assault Prevention Among College Students	N/A
Completed	`NCT05773027` - Integrated Alcohol and Sexual Assault Intervention for College Men	N/A
Completed	`NCT05892692` - Nexus of Risk: Sexual Assault, Alcohol Use, and Risky Sex Among College Women	N/A
Completed	`NCT05065918` - Text Message Intervention for Alcohol Use and Sexual Violence in College Students	N/A
Recruiting	`NCT05345405` - Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors	N/A
Recruiting	`NCT05738837` - An Evaluation of a Sexual Assault Resistance Program for Adolescent Girls	N/A
Completed	`NCT04089137` - Alcohol and Violence Prevention for College Students	N/A
Completed	`NCT03820609` - Interactive Digital Intervention to Prevent Violence Among Young Adults	N/A
Completed	`NCT02384642` - Creating Opportunities Through Mentoring, Parenting and Safe Spaces - Democratic Republic of Congo	N/A
Completed	`NCT04797741` - Adapting an Evidence-based Sexual Assault Prevention Intervention for Women Undergraduates for Online Delivery	N/A
Active, not recruiting	`NCT04564599` - The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents
Completed	`NCT04950686` - Study of Long-term Efficacy and Mechanisms Underlying the Impact of a Web-based Sexual and Relationship Health Promotion Program With Young Adult Community College Students	N/A
Completed	`NCT04691492` - Protecting Allies in Risky Situations	N/A
Completed	`NCT03111056` - Web-Based Treatment of Heavy Drinking Among Women With a History of Sexual Trauma	N/A
Not yet recruiting	`NCT06183385` - Detection of Saliva by Immunoaffinity and Mass Spectrometry	N/A
Not yet recruiting	`NCT06101056` - Code of Respect (X-CoRe): Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Evaluation of an Online Sexual Assault Resistance Program (IDEA3) — IDEA3

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms